An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin
R. Goel, E. Chouinard, D. J. Stewart, S. Huan, H. Hirte, S. Stafford, B. Waterfield, J. Roach, C. Lathia, V. Agarwal, R. Humphrey, W. Walsh, S. Matthews, L. SeymourVolume:
23
Language:
english
Pages:
9
DOI:
10.1023/b:drug.0000047107.35764.d9
Date:
January, 2005
File:
PDF, 86 KB
english, 2005